Kirk Allen Coleman

Kirk Allen Coleman appears in our data through filings on TFF Pharmaceuticals, Inc. shares, published by SEC (Form 4). In total, 17 filings cover trades dated from 25 October 2019 to 3 July 2024.

The open-market side counts 6 purchases for €31k alongside 5 sales for €529k. Netting one side against the other leaves €498k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant and 5 option exercises.

Half of the purchases are above €4,927 and half below. 6 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

On 8 July 2024 came the latest disclosure, a share grant in TFF Pharmaceuticals, Inc. The last purchase on record was published on 15 August 2023, which is 1,166 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.